REHABILIA TECHNOLOGIES SRL

Neuromotor rehabilitation is one of the most delicate areas of medicine, where the quality of recovery depends not only on the therapist's skill but on the frequency, precision, and measurability of exercises. REHABILIA TECHNOLOGIES, a Milan-based medtech startup, has developed PhiCube — a device designed to make rehabilitation more effective, measurable, and engaging for both patients and the healthcare professionals who support them. PhiCube was presented at the European Researchers' Night in Milan, a stage that signals the project's still deeply research-oriented nature while also reflecting an ambition to reach a broader audience. The target is rehabilitation centres, occupational therapists, paediatric facilities, and healthcare professionals working with robotic and interactive technologies for motor rehabilitation and habilitation. The market for technology-assisted rehabilitation is in structural growth, driven by the ageing of the European population, the rise of neurological conditions, and pressure on healthcare systems to reduce hospital stays by shifting part of the therapeutic process to outpatient or home settings. A solution like PhiCube, combining interactive technology with functional assessment capabilities, responds to this demand with a product positioned at the intersection of a medical device and a patient engagement tool. The primary challenge for REHABILIA is the one typical of European medtech: navigating regulatory processes, building robust clinical evidence, and scaling in a market fragmented across national healthcare systems.